openPR Logo
Press release

Meningococcal vaccines market to witness major growth by 2026

03-11-2020 02:13 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Meningococcal Vaccines Market

Meningococcal Vaccines Market

According to a new report published by Allied Market Research, titled, "Meningococcal Vaccines Market by Types (Quadrivalent vaccines, Bivalent vaccines, Serogroup A, Serogroup B, Serogroup X) - Global Opportunity Analysis and Industry Forecast, 2020-2027". The global market size of Meningococcal Vaccines is $XX million in 2019 with XX CAGR, and it is expected to reach $XX million by the end of 2026 with a CAGR of XX% from 2020 to 2027.

Click Here To Access Free Sample Report https://www.alliedmarketresearch.com/request-toc-and-sample/330

This market is classified based on its geography into North America, Europe, Asia-Pacific and rest of the world (RoW). North American market is the highest revenue generating region for this vaccine.
Competitive Landscape
The major players in this market are Sanofi S.A., Novartis International, GlaxoSmithKline, Pfizer Inc., Serum Institute of India Ltd., JN-International Medical Corporation, Nuron Biotech, Baxter International and Biomed Pvt. Ltd. Novartis International with its new product is dominating the market. It has come up with a new vaccine named Baxsero, which has proved to be very beneficial in preventing meningitis. Pfizer Inc. is planning to target adolescent with their vaccine.

KEY BENEFITS
o Estimations are made by considering current market trends, and future potential investment for analysis period 2014-2020
o Benefits of meningococcal vaccines in prevention of meningitis are explained in the report
o In-depth analysis of market growth drivers, restraints and opportunities is done to assist the stakeholders in understanding the various factors affecting this market
o Macro environmental analysis of the market is done using Porter's five forces model to analyze the various components of this industry.
o The market is analyzed based on its type and geography to help the stakeholders in understanding the market and its trends.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/330

KEY MARKETS SEGMENTS
Market by Types
o Quadrivalent vaccines
o Bivalent vaccines
o Serogroup A
o Serogroup B
o Serogroup X

Market by Geography
o North America
o Europe
o Asia-pacific
o RoW

Obtain Report Details: https://www.alliedmarketresearch.com/meningococcal-vaccines-market

Related Reports:
Medical Image Processing Market
https://www.alliedmarketresearch.com/medical-image-processing-market

Macular Edema and Macular Degeneration Market
https://www.alliedmarketresearch.com/macular-edema-and-macular-degeneration-market

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Life Science Market: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Meningococcal vaccines market to witness major growth by 2026 here

News-ID: 1962395 • Views: 115

More Releases from Allied Market Research

Chemical Intermediates Market : Latest Market Trends & Forecast are being Done a …
Allied Market Research published a new report, titled, Chemical Intermediates Market: Global Opportunity Analysis and Industry Forecast, 2020–2027. The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter’s Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to
Infant Sling Market 2020 Detailed Analysis, Size Estimates, Share, Trends, Key P …
Infant sling is a baby care product, designed to hold and carry the baby on one’s chest or back. Infant slings are made from soft fabric that holds the baby. This product is designed for durability, safety, and comfort level of infants. Infant Slings are also known as Baby-Wearing. They provide mobility and convenience especially when pushing a stroller is not a choice. Also, it enables the care giver to
Cable Conduit Systems Market: Growing Demand for Safer and Secure Wiring Systems …
Allied Market Research published a new report, titled, “Cable Conduit Systems Market by Type (Rigid Cable Conduit System, Metallic, Non-Metallic, Flexible Cable Conduit System, Metallic, Non-Metallic), End Use (Manufacturing, Commercial construction, Residential construction, Intelligent transportation systems) - Global Opportunity Analysis and Industry Forecast, 2019-2026.” The research report offers an in-depth analysis of the current market scenario, estimates, revolving aspects, and dynamic forces of the industry from 2019 to 2026 to identify
Smart Exoskeleton Market Applications, Trends, and Investment Opportunities | Ma …
Allied Market Research published a new report, titled, “Smart Exoskeleton Market by Component (Sensors, Actuators, Power Source, Control System, and Others), Type (Soft Exoskeleton and Rigid Exoskeleton), Body Part (Upper Body, Lower Body, and Full Body) and Application (Industrial, Healthcare, Military, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2026.” The research report offers an in-depth analysis of the current market scenario, estimates, revolving aspects, and dynamic forces of the industry

All 5 Releases


More Releases for Meningococcal

Global Meningococcal Vaccines Market Research Report
This report studies the global Meningococcal Vaccines market status and forecast, categorizes the global Meningococcal Vaccines market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report GlaxoSmithKline JN-International Medical Novartis International Sanofi Pfizer Baxter International Geographically, this report studies the top producers and
Meningococcal Vaccines Market Growth by 2028 | GlaxoSmithKline, Polysaccharide M …
Partnerships between the private sector and public institutions have been the chief agenda of global public health initiatives. The last few years have witnessed an increase in several private-public partnerships specifically focussing on vaccine provision in developing countries. Partnerships like the International Coordinating Group on Vaccine Provision for Epidemic Meningitis Control (ICG) help magnify the vaccine outreach to remote areas of the world with the maximum need. The governments of
Meningococcal Vaccines Market Analysis By 2028 | GlaxoSmithKline, Sanofi, Pfizer
Partnerships between the private sector and public institutions have been the chief agenda of global public health initiatives. The last few years have witnessed an increase in several private-public partnerships specifically focussing on vaccine provision in developing countries. Partnerships like the International Coordinating Group on Vaccine Provision for Epidemic Meningitis Control (ICG) help magnify the vaccine outreach to remote areas of the world with the maximum need. The governments of
Meningococcal Vaccines Market | Rising Incidence of Meningococcal Disease Propel …
The global Meningococcal Vaccines Market consists of a good number of established players who are on a quest to expand their market shares. The competition in the market has been stiffening over the past decade, partly due to the innovative business strategies of leading players, and majorly on account of the continual entry of new players. The companies operating in the pharmaceutical industry can easily expand their horizons by manufacturing
Meningococcal Vaccines Market: Regional & Competitive Analysis
A new Transparency Market Research report states that the global meningococcal vaccines market stood at US$1.5 bn in 2013 and is predicted to reach US$4.4 bn in 2022. It is expected to expand at a CAGR of 12.40% from 2014 to 2022. The title of the report is “Meningococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2022”. View Full Report: http://www.transparencymarketresearch.com/meningococcal-vaccines-market.html As per the
Meningococcal Vaccines Market Worth US$ 4.4 Billion Globally by 2022
New York, April 06: Market Research Engine has published a new report titled as “Meningococcal Vaccines Market By Type Analysis (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, Men B Vaccines) and By Regional Analysis – Global Forecast by 2016 - 2022” Meningococcal meningitis, otherwise called cerebrospinal meningitis, is brought on by Neisseria meningitides (Nm) microscopic organisms. It is an infectious disease of the layers encompassing the cerebrum and spinal line and transmits